Phase II Clinical Trial of Clenbuterol in Adult Patients With Pompe Disease Stably Treated With Enzyme Replacement Therapy
Latest Information Update: 01 Apr 2026
At a glance
- Drugs Clenbuterol (Primary)
- Indications Glycogen storage disease type II
- Focus Therapeutic Use
Most Recent Events
- 01 Apr 2026 New trial record